Cargando…
Consistency of plasma glucagon levels in patients with type 1 diabetes after a 1‐year period
Recent progress in research on glucagon and α‐cells highlights their pathophysiological roles in diabetes. We previously showed that plasma glucagon levels measured by newly developed enzyme‐linked immunosorbent assay were dysregulated in patients with type 1 diabetes with respect to plasma glucose...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078088/ https://www.ncbi.nlm.nih.gov/pubmed/31465632 http://dx.doi.org/10.1111/jdi.13134 |
_version_ | 1783507541895938048 |
---|---|
author | Kawamori, Dan Katakami, Naoto Takahara, Mitsuyoshi Miyashita, Kazuyuki Takebe, Satomi Yasuda, Tetsuyuki Matsuoka, Taka‐aki Shimomura, Iichiro |
author_facet | Kawamori, Dan Katakami, Naoto Takahara, Mitsuyoshi Miyashita, Kazuyuki Takebe, Satomi Yasuda, Tetsuyuki Matsuoka, Taka‐aki Shimomura, Iichiro |
author_sort | Kawamori, Dan |
collection | PubMed |
description | Recent progress in research on glucagon and α‐cells highlights their pathophysiological roles in diabetes. We previously showed that plasma glucagon levels measured by newly developed enzyme‐linked immunosorbent assay were dysregulated in patients with type 1 diabetes with respect to plasma glucose levels, suggesting dysregulated secretion. In the current study, the annual change in plasma glucagon levels was assessed in these same patients. We found that the plasma glucagon levels in the 66 Japanese patients involved in the study were significantly correlated between both years. In addition, they were significantly associated with serum blood urea nitrogen levels in a multivariate linear regression analysis, as reported in our previous study. The statistical correlation in glucagon levels between annual checkups and the sustained significant correlation between glucagon and blood urea nitrogen suggest a constant dysregulation of glucagon in association with altered amino acid metabolism in patients with type 1 diabetes. |
format | Online Article Text |
id | pubmed-7078088 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70780882020-03-19 Consistency of plasma glucagon levels in patients with type 1 diabetes after a 1‐year period Kawamori, Dan Katakami, Naoto Takahara, Mitsuyoshi Miyashita, Kazuyuki Takebe, Satomi Yasuda, Tetsuyuki Matsuoka, Taka‐aki Shimomura, Iichiro J Diabetes Investig Articles Recent progress in research on glucagon and α‐cells highlights their pathophysiological roles in diabetes. We previously showed that plasma glucagon levels measured by newly developed enzyme‐linked immunosorbent assay were dysregulated in patients with type 1 diabetes with respect to plasma glucose levels, suggesting dysregulated secretion. In the current study, the annual change in plasma glucagon levels was assessed in these same patients. We found that the plasma glucagon levels in the 66 Japanese patients involved in the study were significantly correlated between both years. In addition, they were significantly associated with serum blood urea nitrogen levels in a multivariate linear regression analysis, as reported in our previous study. The statistical correlation in glucagon levels between annual checkups and the sustained significant correlation between glucagon and blood urea nitrogen suggest a constant dysregulation of glucagon in association with altered amino acid metabolism in patients with type 1 diabetes. John Wiley and Sons Inc. 2019-09-18 2020-03 /pmc/articles/PMC7078088/ /pubmed/31465632 http://dx.doi.org/10.1111/jdi.13134 Text en © 2019 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Articles Kawamori, Dan Katakami, Naoto Takahara, Mitsuyoshi Miyashita, Kazuyuki Takebe, Satomi Yasuda, Tetsuyuki Matsuoka, Taka‐aki Shimomura, Iichiro Consistency of plasma glucagon levels in patients with type 1 diabetes after a 1‐year period |
title | Consistency of plasma glucagon levels in patients with type 1 diabetes after a 1‐year period |
title_full | Consistency of plasma glucagon levels in patients with type 1 diabetes after a 1‐year period |
title_fullStr | Consistency of plasma glucagon levels in patients with type 1 diabetes after a 1‐year period |
title_full_unstemmed | Consistency of plasma glucagon levels in patients with type 1 diabetes after a 1‐year period |
title_short | Consistency of plasma glucagon levels in patients with type 1 diabetes after a 1‐year period |
title_sort | consistency of plasma glucagon levels in patients with type 1 diabetes after a 1‐year period |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078088/ https://www.ncbi.nlm.nih.gov/pubmed/31465632 http://dx.doi.org/10.1111/jdi.13134 |
work_keys_str_mv | AT kawamoridan consistencyofplasmaglucagonlevelsinpatientswithtype1diabetesaftera1yearperiod AT katakaminaoto consistencyofplasmaglucagonlevelsinpatientswithtype1diabetesaftera1yearperiod AT takaharamitsuyoshi consistencyofplasmaglucagonlevelsinpatientswithtype1diabetesaftera1yearperiod AT miyashitakazuyuki consistencyofplasmaglucagonlevelsinpatientswithtype1diabetesaftera1yearperiod AT takebesatomi consistencyofplasmaglucagonlevelsinpatientswithtype1diabetesaftera1yearperiod AT yasudatetsuyuki consistencyofplasmaglucagonlevelsinpatientswithtype1diabetesaftera1yearperiod AT matsuokatakaaki consistencyofplasmaglucagonlevelsinpatientswithtype1diabetesaftera1yearperiod AT shimomuraiichiro consistencyofplasmaglucagonlevelsinpatientswithtype1diabetesaftera1yearperiod |